SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is facing intense scrutiny as investors continue to debate its long-term viability following persistent underperformance during broader market rallies. Community sentiment remains deeply polarized, with active discussions focused on Cathie Wood's rebalancing strategy and the fund's heavy exposure to speculative growth names versus more stable market leaders.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap is trending as the community rallies around a highly anticipated governance proposal to activate a fee switch and initiate a large-scale token burn. Traders are actively debating the potential for increased protocol revenue and deflationary pressure, with sentiment shifting toward bullish as technical indicators show strengthening momentum.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending as institutional investors closely track the stock's consolidation patterns, membership growth, and its ability to maintain margin improvements ahead of upcoming earnings. The community is actively debating the stock's valuation as a healthcare technology disruptor, with long-term bullish sentiment fueled by recent leadership share purchases and technical signals suggesting a potential breakout toward higher price targets.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is currently a major topic of debate as the community intensely discusses its recent price decline, shifting tokenomics, and ongoing technical developments. Investors are polarized, with some identifying deep-value accumulation opportunities in current price levels while others express frustration over extended stagnation and market performance.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as community members speculate on a potential breakout, driven by the project's ongoing retail expansions and brand partnerships. While some investors are accumulating the token in anticipation of broader altcoin market strength, the community remains divided, with active debates centered on its historical performance compared to other meme coins and the impact of broader regulatory uncertainty on the sector.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending as the community remains deeply divided between those accumulating through market volatility and critics who point to stagnant price action and structural skepticism. Investors are actively debating the project's long-term utility versus its history of underperformance, while many weigh in on whether current price levels represent a generational buying opportunity or a persistent downward trend.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending amid heightened volatility as investors debate the impact of rising competition from unregulated prediction markets against the company's efforts to scale its own betting infrastructure. The community is sharply divided between those monitoring Michael Burrys reported accumulation of shares and skeptics who are concerned about ongoing management skepticism and the stock's persistent inability to sustain upward momentum.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is seeing significant market interest driven by an expanding cloud storage footprint and strong momentum within the AI infrastructure sector, specifically following a major multi-year storage agreement with CoreWeave. Community sentiment is mixed as investors weigh this growth potential against concerns over share dilution risks and the stock's recent volatility.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly remains a central focus for investors as it navigates a high-profile legal dispute with Novo Nordisk over marketing claims, while simultaneously solidifying its position in the obesity and neuroscience sectors with new clinical data and acquisition moves. The community continues to debate the sustainability of Lilly's premium valuation amidst shifting rotation into healthcare and ongoing excitement regarding its robust pipeline and manufacturing capacity.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is gaining traction as investors anticipate the platform's upcoming expansion to the Ethereum mainnet and a token merger. The community remains focused on Aerodrome's dominant liquidity position on the Base network and sees its integration with broader DeFi infrastructure as a long-term growth catalyst despite recent market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2026 Business and Financial Updates

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet...

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Ionis Begins Dosing in Phase I/II Dravet Syndrome Study

IONS doses first patient in the phase I/II ASCEND study of ION337, marking a key step in developing a potential disease-modifying treatment for Dravet syndrome.

Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer

Stoke Therapeutics Announces Completion of Enrollment of 162 Patients Into the Phase 3 EMPEROR Study of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome

4 Biotech Stocks Investors Should Watch in 2026

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position LQDA, IMNM, STOK and IMCR well in this volatile sector. 

Stoke Therapeutics (STOK) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Stoke Therapeutics (STOK) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Stoke Therapeutics, Inc. (STOK) Reports Q1 Results and Business Updates

Stoke Therapeutics, Inc. (STOK) Reports Q1 Results and Business Updates...

Stoke Therapeutics to Present at Upcoming Investor Conferences in June

$STOK Q4 '25 Earnings Results & Recap

Stoke Therapeutics expects its cash, cash equivalents, and marketable securities of approximately $390.9M as of December 31, 2025, will fund operations into 2028, and anticipates pivotal Phase 3 data for zorevunersen in mid-2027.

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

Stoke Therapeutics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.80	--	--	N/A
Q1 '26	-$0.81	-$0.79	2.17%	BEAT
Q4 '25	-$0.93	--	--	N/A
Q3 '25	-$0.57	-$0.65	-14.40%	MISSED
Q2 '25	-$0.51	-$0.40	21.88%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings